developing a cbpt
Phase 3
Completed
- Conditions
- ADHD.Attention-deficit hyperactivity disorder, combined type
- Registration Number
- IRCT20181104041548N1
- Lead Sponsor
- niversity of Tehran
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 17
Inclusion Criteria
not receive cognitive-behavioral therapy (CBT)
Exclusion Criteria
inability to read and write
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Symptoms of ADHD. Timepoint: post test and 3 month follow up. Method of measurement: Child Symptom Inventory-4 (CSI-4).
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the effectiveness of family-based cognitive-behavioral play therapy in ADHD combined type?
How does family-based cognitive-behavioral play therapy compare to standard-of-care stimulant medications for ADHD combined type in children?
Are there specific biomarkers that predict response to cognitive-behavioral play therapy in ADHD combined type populations?
What are the potential adverse events associated with family-based cognitive-behavioral play therapy for ADHD combined type in pediatric patients?
What combination approaches or alternative therapies are being explored alongside cognitive-behavioral play therapy for ADHD combined type?